You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ezetimibe

Showing 26 - 50 of 429
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cholesterol Trial (ezetimibe, Comparator: Placebo (unspecified), simvastatin)

Completed
  • Cholesterol
  • ezetimibe
  • +2 more
  • (no location specified)
Feb 7, 2022

Pharmacokinetics, Safety Trial in Qingdao (Reference preparation-Reference preparation-Test Preparation, Reference

Enrolling by invitation
  • Pharmacokinetics
  • Safety
  • Reference preparation-Reference preparation-Test Preparation
  • +2 more
  • Qingdao, Shandong, China
    Phase I clinical research center
Jul 28, 2022

Hypercholesterolemia Trial (Ezetimibe, atorvastatin)

Completed
Has Results
  • Hypercholesterolemia
  • (no location specified)
Feb 7, 2022

Hypercholesterolemia Trial (Ezetimibe, Simvastatin)

Completed
Has Results
  • Hypercholesterolemia
  • (no location specified)
Feb 7, 2022

Ezetimibe onSelect Population of Filipinos With

Completed
Has Results
  • Primary Hypercholesterolemia
  • Homozygous Familial Hypercholesterolemia
  • Ezetimibe
  • (no location specified)
Feb 7, 2022

Hypercholesterolemia Trial (MK0653, ezetimibe / Duration of Treatment: 4 Weeks)

Completed
  • Hypercholesterolemia
  • MK0653, ezetimibe / Duration of Treatment: 4 Weeks
  • (no location specified)
Feb 7, 2022

Hypercholesterolemia, Atherosclerosis Trial (Ezetimibe + Atorvastatin, Atorvastatin)

Completed
  • Hypercholesterolemia
  • Atherosclerosis
  • (no location specified)
Feb 7, 2022

Hypercholesterolaemia, Atherosclerosis Trial (Ezetimibe + Simvastatin, Simvastatin)

Completed
  • Hypercholesterolaemia
  • Atherosclerosis
  • (no location specified)
Feb 7, 2022

Cholesterol Trial (ezetimibe, Comparator: cyclosporine)

Completed
  • Cholesterol
  • ezetimibe
  • Comparator: cyclosporine
  • (no location specified)
Feb 7, 2022

Diabetes, Type 2 Trial (MK0653, ezetimibe / Duration of Treatment: 30 Weeks, Comparator : ezetimibe (+) simvastatin / Duration

Completed
  • Diabetes Mellitus, Type 2
  • MK0653, ezetimibe / Duration of Treatment: 30 Weeks
  • Comparator : ezetimibe (+) simvastatin / Duration of Treatment: 30 Weeks
  • (no location specified)
Feb 7, 2022

Cardiovascular Diseases, NSTEMI, STEMI Trial in Oakland (Bempedoic Acid / Ezetimibe Oral Tablet, Placebo)

Not yet recruiting
  • Cardiovascular Diseases
  • +2 more
  • Bempedoic Acid / Ezetimibe Oral Tablet
  • Placebo
  • Oakland, California
    Kaiser Permanente Northern California Division of Research
Mar 1, 2022

Hypercholesterolemia Trial (ezetimibe, statins)

Completed
  • Hypercholesterolemia
  • (no location specified)
Feb 7, 2022

Pharmacokinetics, Safety Trial (Test Preparation-Reference preparation, Reference preparation-Test Preparation)

Not yet recruiting
  • Pharmacokinetics
  • Safety
  • Test Preparation-Reference preparation
  • Reference preparation-Test Preparation
  • (no location specified)
May 16, 2022

Hyperlipidemia Trial (Ezetimibe, Ezetimibe/atorvastatin 10mg/10mg FDC, Atorvastatin 10mg)

Completed
  • Hyperlipidemia
  • Ezetimibe
  • +4 more
  • (no location specified)
Feb 7, 2022

Hypercholesterolemia, Coronary Heart Disease Trial (ezetimibe, )

Completed
  • Hypercholesterolemia
  • Coronary Heart Disease
  • ezetimibe
  • placebo
  • (no location specified)
Feb 7, 2022

Ezetimibe Achieved in Co-administration Therapy With Statins

Completed
Has Results
  • Hypercholesterolemia
  • (no location specified)
Feb 7, 2022

Hypercholesterolemia, Dyslipidemia Trial in Seoul (Ezetimibe/Atorvastatin 10/5 mg, Atorvastatin 5mg, Ezetimibe 10mg)

Completed
  • Hypercholesterolemia, Dyslipidemia
  • Ezetimibe/Atorvastatin 10/5 mg
  • +7 more
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Jul 24, 2023

Atherosclerosis, Hypercholesterolemia, Hyperlipoproteinemia Type II Trial (ezetimibe (plus simvastatin), (plus simvastatin))

Completed
  • Atherosclerosis
  • +2 more
  • ezetimibe (plus simvastatin)
  • placebo (plus simvastatin)
  • (no location specified)
Feb 7, 2022

Fixed-dose Combination Rosuvastatin/Ezetimibe for Dyslipidaemia

Completed
  • Dyslipidemias
  • Rosuvastatin 10 or 20mg /Ezetimibe 10 mg Fixed Dose
  • Mexico City, Mexico
    Laboratorio Silanes, S.A. de C.V.
Feb 28, 2022

Essential Hypertension, Primary Hypercholesterolemia Trial in Seoul (Fimasartan, Ezetimibe/Atorvastatin, Fimasartan Placebo)

Not yet recruiting
  • Essential Hypertension
  • Primary Hypercholesterolemia
  • Seoul, Korea, Republic of
    Severance Hospital
Jun 26, 2023

Hypercholesterolemia, Hyperlipidemia Trial (Vytorin + Niaspan, Vytorin, Niaspan)

Completed
  • Hypercholesterolemia
  • Hyperlipidemia
  • Vytorin + Niaspan
  • +2 more
  • (no location specified)
Feb 7, 2022

Hypercholesterolemia, Coronary Arteriosclerosis Trial (Ezetimibe, Placebo, Atorvastatin 10 mg)

Completed
Has Results
  • Hypercholesterolemia
  • Coronary Arteriosclerosis
  • Ezetimibe
  • +2 more
  • (no location specified)
Feb 7, 2022

Hypercholesterolemia Trial (SCH 58235, pitavastatin)

Completed
  • Hypercholesterolemia
  • (no location specified)
Feb 7, 2022

Hypercholesterolemia Trial (Ezetimibe + Statin (simvastatin, atorvastatin, or pravastatin), Double Statin (simvastatin,

Completed
Has Results
  • Hypercholesterolemia
  • Ezetimibe + Statin (simvastatin, atorvastatin, or pravastatin)
  • Double Statin (simvastatin, atorvastatin, or pravastatin)
  • (no location specified)
Feb 7, 2022

Atheroscleroses, Coronary Trial in Seoul (Rosuvastatin and Ezetimibe, Rosuvastatin)

Active, not recruiting
  • Atheroscleroses, Coronary
  • Seoul, Korea, Republic of
  • +1 more
Oct 1, 2022